EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Influence of high serum alpha fetoprotein on patients with gastric cancer

Ming‐Yao Chen, Wen‐Liang Fang, Kuo‐Hung Huang, Yu‐Hsin Lai, Hwai‐Jeng Lin

Advances in Digestive Medicine · 2017

DOI: 10.1002/aid2.12050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Digestive Medicine, 2017. Verfasst von Ming‐Yao Chen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tomorrow Medical Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Patients with alphafetoprotein (AFP)‐producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial.

Methods

We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of > 100 ng/mL ( n = 30) and of ≦ 20 ng/mL ( n = 1236). Clinical manifestations were compared between these two groups.

Results

Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1% vs. 0%) and advanced gastric cancer was less frequent (69.9% vs. 100%) in the AFP ≦ 20 ng/mL group ( p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4% vs. 43.3%, p < 0.001 and 60.7% vs. 93.3%, p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7% vs 27.1%, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7% vs 37.9%, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7% vs 27.1%, p < 0.0001).

Conclusions

Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis. Copyright © 2017, The Gastroenterological Society of Taiwan, The Digestive Endoscopy Society of Taiwan and Taiwan Association for the Study of the Liver.

Förderung

  • Tomorrow Medical Foundation

Zitieren

APA

Chen, M., Fang, W., Huang, K., Lai, Y., & Lin, H. (2017). Influence of high serum alpha fetoprotein on patients with gastric cancer. Advances in Digestive Medicine. https://doi.org/10.1002/aid2.12050

Vancouver

Chen M, Fang W, Huang K, Lai Y, Lin H. Influence of high serum alpha fetoprotein on patients with gastric cancer. Advances in Digestive Medicine. 2017. doi:10.1002/aid2.12050

BibTeX
@article{Chen2017,
  author = {Chen, Ming‐Yao and Fang, Wen‐Liang and Huang, Kuo‐Hung and Lai, Yu‐Hsin and Lin, Hwai‐Jeng},
  title = {Influence of high serum alpha fetoprotein on patients with gastric cancer},
  journal = {Advances in Digestive Medicine},
  year = {2017},
  doi = {10.1002/aid2.12050}
}
Kostenlos starten →